Total Payments
$5,136
2024 Payments
$1,420
Companies
36
Transactions
286
Medicare Patients
1,441
Medicare Billing
$129,228
Payment Breakdown by Category
Food & Beverage$5,136 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,136 | 286 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $565.97 | 39 | $0 (2024) |
| GlaxoSmithKline, LLC. | $560.71 | 25 | $0 (2024) |
| ABBVIE INC. | $518.65 | 31 | $0 (2024) |
| PFIZER INC. | $385.97 | 27 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $379.18 | 19 | $0 (2024) |
| Lilly USA, LLC | $358.35 | 21 | $0 (2024) |
| Amgen Inc. | $288.09 | 21 | $0 (2024) |
| Mylan Specialty L.P. | $268.26 | 15 | $0 (2023) |
| IDORSIA PHARMACEUTICALS US INC | $242.90 | 15 | $0 (2024) |
| Medtronic, Inc. | $179.26 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,420 | 73 | Lilly USA, LLC ($203.39) |
| 2023 | $1,860 | 102 | PFIZER INC. ($201.17) |
| 2022 | $1,703 | 102 | Novo Nordisk Inc ($260.23) |
| 2021 | $153.79 | 9 | AbbVie Inc. ($33.72) |
All Payment Transactions
286 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: Inflammation | ||||||
| 11/18/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/14/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Cardio-renal | ||||||
| 11/05/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.92 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: PSYCHIATRY | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $31.02 | General |
| Category: DIABETES | ||||||
| 10/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Diabetes | ||||||
| 10/16/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Spinal Cord Stimulator | ||||||
| 10/10/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: Inflammation | ||||||
| 10/08/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: PAIN | ||||||
| 10/04/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $24.01 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 10/02/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: VACCINES | ||||||
| 09/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: Obesity | ||||||
| 09/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: Oncology | ||||||
| 09/23/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: Insomnia | ||||||
| 09/19/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: VACCINES | ||||||
| 09/18/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $115.43 | General |
| Category: RESPIRATORY | ||||||
| 09/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Diabetes | ||||||
| 09/03/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Bone Health | ||||||
| 08/22/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Diabetes | ||||||
| 08/21/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 579 | 712 | $169,156 | $52,124 |
| 2022 | 14 | 808 | 1,034 | $208,493 | $71,783 |
| 2021 | 2 | 54 | 58 | $12,848 | $5,321 |
Total Patients
1,441
Total Services
1,804
Medicare Billing
$129,228
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 192 | 295 | $83,485 | $22,610 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 154 | 154 | $46,046 | $18,045 | 39.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 35 | 35 | $15,330 | $3,346 | 21.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 47 | 55 | $10,560 | $2,802 | 26.5% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 11 | 11 | $4,796 | $1,657 | 34.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 20 | 20 | $2,180 | $1,439 | 66.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 21 | 21 | $777.00 | $649.11 | 83.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 34 | 34 | $1,598 | $581.74 | 36.4% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 27 | 33 | $1,353 | $407.55 | 30.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 16 | 16 | $752.00 | $273.76 | 36.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 27 | $1,674 | $249.60 | 14.9% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2023 | 11 | 11 | $605.00 | $63.42 | 10.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 198 | 334 | $94,522 | $30,765 | 32.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 151 | 151 | $45,149 | $19,919 | 44.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 119 | 177 | $33,984 | $9,125 | 26.9% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 16 | 16 | $6,976 | $2,719 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $9,636 | $2,282 | 23.7% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 94 | 94 | $4,418 | $1,778 | 40.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 22 | 22 | $2,398 | $1,501 | 62.6% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 74 | 74 | $3,478 | $1,426 | 41.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 23 | 23 | $851.00 | $648.76 | 76.2% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 14 | 16 | $2,080 | $610.35 | 29.3% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 34 | 48 | $1,968 | $597.07 | 30.3% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 31 | $1,922 | $329.00 | 17.1% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2022 | 15 | 15 | $825.00 | $58.39 | 7.1% |
About Dr. Nicole Ryman, MD
Dr. Nicole Ryman, MD is a Internal Medicine healthcare provider based in Cedar Park, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2018. The National Provider Identifier (NPI) number assigned to this provider is 1427552579.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicole Ryman, MD has received a total of $5,136 in payments from pharmaceutical and medical device companies, with $1,420 received in 2024. These payments were reported across 286 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,136).
As a Medicare-enrolled provider, Ryman has provided services to 1,441 Medicare beneficiaries, totaling 1,804 services with total Medicare billing of $129,228. Data is available for 3 years (2021–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Cedar Park, TX
- Active Since 03/22/2018
- Last Updated 06/05/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1427552579
Products in Payments
- FARXIGA (Drug) $346.23
- Rybelsus (Drug) $287.94
- JARDIANCE (Drug) $287.68
- NURTEC ODT (Drug) $252.68
- QUVIVIQ (Drug) $242.90
- TRELEGY ELLIPTA (Drug) $230.71
- Ozempic (Drug) $219.07
- UBRELVY (Drug) $170.48
- INTELLIS ADAPTIVESTIM (Device) $155.61
- EVENITY (Biological) $151.85
- AREXVY (Drug) $148.66
- Yupelri (Drug) $141.43
- QULIPTA (Drug) $137.90
- MOUNJARO (Drug) $137.18
- YUPELRI (Drug) $126.83
- ELIQUIS (Drug) $114.27
- Kerendia (Drug) $112.80
- LEQVIO (Drug) $110.56
- Cologuard Collection Kit (Device) $106.78
- Otezla (Drug) $100.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Cedar Park
Dr. Nikhil Agarwal, M.d, M.D
Internal Medicine — Payments: $16,099
Internal Medicine $16,099
Dr. Joshua Reinhart, Md, MD
Internal Medicine — Payments: $8,345
Internal Medicine $8,345
Dr. Ryan Cho, M.d, M.D
Internal Medicine — Payments: $4,835
Internal Medicine $4,835
Dr. Sarika Deshmukh, M.d, M.D
Internal Medicine — Payments: $4,424
Internal Medicine $4,424
Andrew Shaw, M.d, M.D
Internal Medicine — Payments: $4,059
Internal Medicine $4,059
Weiwei Cao, M.d., Phd, M.D., PHD
Internal Medicine — Payments: $4,050
Internal Medicine $4,050